New Results
Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
David H. Drewry, Carrow I. Wells, David M. Andrews, Richard Angell, Hassan Al-Ali, Alison D. Axtman, Stephen J. Capuzzi, Jonathan M. Elkins, Peter Ettmayer, Mathias Frederiksen, Opher Gileadi, Nathanael Gray, Alice Hooper, Stefan Knapp, Stefan Laufer, Ulrich Luecking, Susanne Müller, Eugene Muratov, R. Aldrin Denny, Kumar S. Saikatendu, Daniel K. Treiber, William J. Zuercher, Timothy M. Willson
doi: https://doi.org/10.1101/104711
David H. Drewry
1Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
Carrow I. Wells
1Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
David M. Andrews
2AstraZeneca, Darwin Building, Cambridge Science Park, Cambridge, CB4 0FZ, UK
Richard Angell
3Drug Discovery Group, Translational Research Office, University College London School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX
Hassan Al-Ali
4Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL-33136, USA
5Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA
Alison D. Axtman
1Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
Stephen J. Capuzzi
6Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, USA
Jonathan M. Elkins
7Structural Genomics Consortium, Universidade Estadual de Campinas - UNICAMP, Campinas, SP, Brazil
Peter Ettmayer
8Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1121, Austria
Mathias Frederiksen
9Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland
Opher Gileadi
10Structural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK
Nathanael Gray
11Harvard Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States
12Department of Cancer Biology, Dana–Farber Cancer Institute, Boston, Massachusetts 02215, United States
Alice Hooper
3Drug Discovery Group, Translational Research Office, University College London School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX
Stefan Knapp
13Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, and Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Straβe 15, D-60438 Frankfurt am Main, DE
Stefan Laufer
14Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany
Ulrich Luecking
15Bayer Pharma AG, Drug Discovery, Müllerstrasse 178, 13353 Berlin, Germany
Susanne Müller
13Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, and Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Straβe 15, D-60438 Frankfurt am Main, DE
Eugene Muratov
6Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, USA
R. Aldrin Denny
16Worldwide Medicinal Chemistry, Pfizer Inc., Cambridge, MA 02139, USA
Kumar S. Saikatendu
17Global Research Externalization, Takeda California, Inc., 10410 Science Center Drive, San Diego, CA 92121, USA
Daniel K. Treiber
18DiscoverX Corporation, 42501 Albrae Street, Fremont, CA 94538
William J. Zuercher
1Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
Timothy M. Willson
1Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
Article usage
Posted January 31, 2017.
Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
David H. Drewry, Carrow I. Wells, David M. Andrews, Richard Angell, Hassan Al-Ali, Alison D. Axtman, Stephen J. Capuzzi, Jonathan M. Elkins, Peter Ettmayer, Mathias Frederiksen, Opher Gileadi, Nathanael Gray, Alice Hooper, Stefan Knapp, Stefan Laufer, Ulrich Luecking, Susanne Müller, Eugene Muratov, R. Aldrin Denny, Kumar S. Saikatendu, Daniel K. Treiber, William J. Zuercher, Timothy M. Willson
bioRxiv 104711; doi: https://doi.org/10.1101/104711
Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
David H. Drewry, Carrow I. Wells, David M. Andrews, Richard Angell, Hassan Al-Ali, Alison D. Axtman, Stephen J. Capuzzi, Jonathan M. Elkins, Peter Ettmayer, Mathias Frederiksen, Opher Gileadi, Nathanael Gray, Alice Hooper, Stefan Knapp, Stefan Laufer, Ulrich Luecking, Susanne Müller, Eugene Muratov, R. Aldrin Denny, Kumar S. Saikatendu, Daniel K. Treiber, William J. Zuercher, Timothy M. Willson
bioRxiv 104711; doi: https://doi.org/10.1101/104711
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)